Latest Breaking News On - Institutional investors weigh in on galmed pharmaceuticals - Page 4 : comparemela.com

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Rating) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 26,400 shares, a drop of 28.5% from the March 15th total of 36,900 shares. Based on an average daily trading volume, of 79,700 shares, the short-interest ratio […]

United kingdomMillennium managementGalmed pharmaceuticalsGalmed pharmaceuticals stock performanceGalmed pharmaceuticals ltdInstitutional investors weigh in on galmed pharmaceuticalsCambridge investment research advisors incRaymond james financial services advisors incNews ratings for galmed pharmaceuticals dailyGet ratingInvestment research advisorsRaymond james financial services advisorsJames financial services advisorsGalmed pharmaceuticals dailyNasdaq glmd